Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Contributing writer

Nicole Golbari,
Stony Brook University School of Medicine
Stonybrook, NY,

Contributing writer Nicole Golbari is a fourth year medical student at Stony Brook University School of Medicine in Stony Brook, New York. She earned her bachelor’s degree in neurobiology from Harvard University in Cambridge, Massachusetts. She is currently completing a one-year clinical research fellowship under the supervision of IPC Board member Dr. Alexa B. Kimball at the Beth Israel Deaconess Medical Center in Boston, Massachusetts.

Last Updated: Apr 15, 2018

Psoriasis News

6/11/2019 9:58:00 AM
6/5/2019 12:03:00 PM
Corticosteroid therapy is regarded as first-line therapy for treating mild psoriasis and recalcitrant lesions. Members of the IPC Topical Therapies Working Group reviewed available international topical corticosteroids guidelines in order to understand current information and to identify areas that would benefit from greater practical guidance for dermatologists.
4/29/2019 7:28:00 AM
4/28/2019 8:26:00 PM
More News

This website uses cookies. Please ensure your cookies are enabled. 
OK